Relying on its groundbreaking achievements and high level of innovation in the development and industrialization of “nano-hydroxyapatite” within the field of inorganic non-metallic materials, Dingan Technology has once again been selected as the lead entity for an innovative project under the “Challenge‑Based Innovation” initiative. This recognition underscores Dingan Technology’s continued national‑level validation of its technical prowess and innovative capabilities in the biomedical materials sector.
2025
11-04
The national key special project has successfully passed acceptance.
Dingan Technology, as a key participating institution, has successfully completed the national key R&D program titled “Engineering and Clinical Application of a Novel Injectable Nanobiomaterial for the Prevention and Treatment of Osteoporosis.” The project focuses on the development of an injectable nano‑biomaterial designed to be delivered via minimally invasive procedures directly into specific sites within bone, thereby stimulating the body’s natural osteogenic processes, promoting bone repair and strengthening, and helping to prevent fragility fractures. By guiding the directional deposition of calcium in bone and enhancing the synthesis of bone matrix proteins, this material holds promise for significantly reducing the risk of fractures.
2025
11-04
Receives ISO 13485 certification again
Dingan Technology has long been committed to the industrialization of critical raw materials, core technologies, and innovative products within the high-end surgical implant device industry chain. The company operates R&D and production facilities for products including “composite ceramic femoral heads,” “zirconia blocks for all-ceramic dentures,” “bioactive materials and high-end bone implants,” and “fillers for medical aesthetic minimally invasive procedures.” It holds manufacturing licenses for “Class III 6846 Implantable Materials and Artificial Organs” and “Class II 17-06 Dental Prosthetic Materials,” and in December 2024, it was further awarded ISO 13485 certification for its medical device quality management system.
2025
11-04
Warm congratulations to Suzhou Dingan Technology Co., Ltd. on successfully obtaining provincial high-tech enterprise certification…
2025
05-23
National-Level Expert Workstation
The “National-Level Expert” Workstation of Wujiang District was established in accordance with the Wujiang Municipal Government Office’s policy on rewarding and funding innovative science and technology talents introduced to Wujiang City in 2012...
2025
06-06
Suzhou Dingan Technology Co., Ltd. has established the Suzhou Postdoctoral…
In order to thoroughly implement the innovation-driven and talent-first development strategies and better leverage the role of postdoctoral research platforms in enterprises’ innovative development...
2025
06-13
Two group standards for surgical implants—alpha‑tricalcium phosphate and strontium calcium phosphate—have been officially released. Additionally, three Chinese invention patents have been granted, covering biomimetic all-ceramic dentures, zirconia ceramic blocks, and transparent hydroxyapatite with mineralized fluorescent tracing. The company also participated in the drafting of one industry standard.
2025
07-11
The organization completed the drafting of two group standards and successfully passed expert technical reviews, and participated in the drafting of one additional group standard. It was awarded the Second Prize for Scientific and Technological Progress of Yunnan Province and obtained certification under the Intellectual Property Management System.
2025
07-11
In 2020, the company was recognized as a qualified entity in the first batch of Jiangsu Province’s enterprise intellectual property management standardization performance evaluations; it obtained two authorized invention patents and is constructing a production base in Changshu for bioactive materials and high-end orthopedic implants.
2025
07-11
The company has been recognized as a high-tech enterprise and was awarded the First Prize for Technological Invention by the Ministry of Education. The project “Engineering and Clinical Application Development of a Novel Injectable Nanobiomaterial for the Prevention and Treatment of Osteoporosis” has received funding from the National Key R&D Program (SQ2019YFC110005); the project “Microstructural Regulation and Bone-Biological Effects of Two-Phase Composite Ceramics in the Repair of Large-Scale Bone Defects” has been selected as a key project by the Jiangsu Provincial Health Commission (K2019010).
2025
07-11